16 Most Promising Long-Term Stocks According to Analysts

Published on December 29, 2023 at 6:45 am by Ramish Cheema in News, Quantitative Investing

In this piece, we will take a look at the 16 most promising long-term stocks according to analysts. If you want to skip our overview of long term investing, then you can take a look at 5 Most Promising Long-Term Stocks According to Analysts.

While investing comes in all sizes and flavors, the one approach that leads to billions of dollars in wealth is typically long term capital appreciation. Investing in the right set of companies, coupled with years of low interest rates to help stimulate stock market growth has produced nearly all of America’s biggest billionaires. Most of the world’s richest men, such as Bill Gates of Microsoft Corporation (NASDAQ:MSFT), Alphabet Inc. (NASDAQ:GOOG) co founders Page & Brin, Tesla, Inc. (NASDAQ:TSLA) co-founder Elon Musk, or Berkshire Hathaway’s Warren Buffett got into the right stocks or set up the right companies decades back and then patiently waited for the shares to appreciate.

Over the long term, stocks tend to produce sizeable returns. For instance, both of Wall Street’s leading stock indexes – the S&P 500 and the NASDAQ Composite – have outpaced inflation. Starting from the year 2000, the former has posted 228% in returns and the latter is up by 357%. So, if you had invested a dollar in either of the indexes, you’d have made more than if you’d bought a security that grew the principal by the annual inflation rate. This makes stocks quite a lucrative way of slowly growing the value of money over time and ensuring that the growth outpaces any inflationary after effects.

Crucially though, just as an inflation protected security also pays a coupon rate annually, stocks also offer a similar opportunity through dividends. Dividends are typically paid by established companies that can balance investor payouts with growth investments. A dividend is a share in a firm’s profits after taxes and interest payments have been accounted for. In financial analysis, models such as the Gordon Growth Model enable investors to evaluate whether dividend growth rates lend a stock adequate intrinsic value to merit an investment. Additionally, the earnings per share (EPS) part of every quarterly and annual earnings release allows them to see how much money a company is paying to investors out of its total earnings. One common metric is a dividend payout ratio which divides the dividends by the EPS and also lets analysts calculate the retention ratio.

When it comes to dividends, they also enable additional returns through share price appreciation. Some investors who do not rely on dividend earnings to meet living expenses or other payouts reinvest the money into the shares. This allows them to earn dividends on dividends and share price appreciation of the new stock bought. This strategy is called compounding, and none other than Warren Buffett is one of its biggest adherents.

Speaking at Berkshire Hathaway’s 2019 Annual Conference, the Oracle of Omaha talked quite a bit about compounding:

It is the primary motivation, but it’s been that for a very, very ,very long time. No matter what was going right in my life, the things that were going badly at Berkshire, I would not feel them you know. I don’t need to be spending my time working on something that makes me feel bad about the results of it when we get through. And it’s something that’s doable, I mean the culture is stronger now than it was 10 years ago and it was stronger then than 10 years previously, it moves slowly, but it goes in the right direction. And when we get chances to deploy the capital, we’ve always tried to make any entity, whether it was the partnership originally or the Berkshire now, or blue chips [inaudible] that are even diversified [inaudible]. We wanted them all to be compounding, in effect be compounding machines that’s why people gave this capital to us and why we put our own capital in. And if failed at that we really felt like we failed. It didn’t make any difference how much money we made from fees or anything like that. We knew what our yardstick was.

So that will continue. I think Berkshire is, better, situated, then it’s ever been except for the fact that size is a drag on performance. I probably wrote that 40 years, I wrote it actually when I closed the partnership to new money when we had like $40 million in it. I said that really the new, the additional capital would drag down returns from a $40 million base so you can imagine how I feel with $368 billion base of capital in Berkshire now. But, this culture is special, it can work, it won’t be the highest compounder by a long shot against many other businesses. I think it’ll be one of the safest ways to make decent money over time butt will depend on the people that follow us.

So, with 2023 heading to a close, we decided to take a look at some promising long term stocks according to analysts. Among these, the top three are Evolus, Inc. (NASDAQ:EOLS), Relay Therapeutics, Inc. (NASDAQ:RLAY), and Valneva SE (NASDAQ:VALN).

Pixabay/Public Domain

Our Methodology

To make our list of the most promising long term stocks according to analysts, we made a list of 40 stocks with market capitalization greater than $300 million and average share ratings of Buy or better, and ranked them according to their average analyst share price target percentage upside. Out of these, the top stocks were the most promising long term stocks according to analysts.

For these stocks we have also mentioned hedge fund sentiment. Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). That’s why we pay very close attention to this often-ignored indicator.

16 Most Promising Long-Term Stocks According to Analysts

16. Xperi Inc. (NYSE:XPER)

Average Analyst Share Price Target Percentage Upside: 63.38%

Average Share Price Target: $18.2

Xperi Inc. (NYSE:XPER) is an American software company that offers technology to enable cable distributors to manage their programming. Its shares are rated Buy on average and analysts have set an average share price target of $18.20.

During Q3 2023, 14 out of the 910 hedge funds part of Insider Monkey’s database had bought and owned Xperi Inc. (NYSE:XPER) ‘s shares. Along with Relay Therapeutics, Inc. (NASDAQ:RLAY), Evolus, Inc. (NASDAQ:EOLS), and Valneva SE (NASDAQ:VALN), it’s a promising long term stock according to analysts.

15. Tango Therapeutics, Inc. (NASDAQ:TNGX)

Average Analyst Share Price Target Percentage Upside: 63.95%

Average Share Price Target: $17.33

Tango Therapeutics, Inc. (NASDAQ:TNGX) is a biotechnology company that develops cancer treatments. The firm has been doing well on the financial front as of late since it has beaten analyst EPS estimates in all four of its latest quarters.

By the end of this year’s third quarter, 19 out of the 910 hedge funds covered by Insider Monkey’s research were the firm’s shareholders.

14. Tyra Biosciences, Inc. (NASDAQ:TYRA)

Average Analyst Share Price Target Percentage Upside: 64.08%

Average Share Price Target: $22.22

Tyra Biosciences, Inc. (NASDAQ:TYRA) is a biotechnology company developing gene based treatments for cancer and other ailments. December 2023 was a crucial month for the firm as it announced the results of the first dosing test of its cancer drug.

Insider Monkey scoured through 910 hedge funds for their September quarter of 2023 shareholdings to discover eight Tyra Biosciences, Inc. (NASDAQ:TYRA) stakeholders. Peter Kolchinsky’s RA Capital Management was the firm’s biggest shareholder among these as it owned a $99 million stake.

13. KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)

Average Analyst Share Price Target Percentage Upside: 65.47%

Average Share Price Target: $20.8

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is a biotechnology company developing treatments for complications resulting from diabetes. It’s one of the strongest rated stocks on our list since the shares are rated Strong Buy on average.

By the end of this year’s third quarter, 24 out of the 910 hedge funds covered by Insider Monkey’s research had bought the firm’s shares. KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)’s largest hedge fund investor is Kevin C. Tang’s Tang Capital Management through its $33 million investment.

12. MAG Silver Corp. (NYSE:MAG)

Average Analyst Share Price Target Percentage Upside: 68.94%

Average Share Price Target: $18.06

MAG Silver Corp. (NYSE:MAG) is a silver property manager and developer headquartered in Vancouver, Canada. The firm has missed analyst EPS estimates in three of its four latest quarters.

Insider Monkey scoured through 910 hedge fund portfolios for their September quarter of 2023 shareholdings to find 11 MAG Silver Corp. (NYSE:MAG) shareholders. Jean-Marie Eveillard’s First Eagle Investment Management was the biggest investor among these due to its $59.3 million stake.

11. Liquidia Corporation (NASDAQ:LQDA)

Average Analyst Share Price Target Percentage Upside: 71.72%

Average Share Price Target: $20.83

Liquidia Corporation (NASDAQ:LQDA) is a biotechnology company developing treatments for people with high blood pressure. It scored a major win in December 2023 when a court held an earlier decision to free Liquidia Corporation (NASDAQ:LQDA) from any restrictions to technology covered by a patent owned by another company.

During this year’s third quarter, 17 out of the 910 hedge funds surveyed by Insider Monkey had bought a stake in the firm. Liquidia Corporation (NASDAQ:LQDA)’s largest shareholder is Derrick Tang’s Kynam Capital as it owns $12.6 million worth of shares.

10. Alta Equipment Group Inc. (NYSE:ALTG)

Average Analyst Share Price Target Percentage Upside: 74.51%

Average Share Price Target: $22.25

Alta Equipment Group Inc. (NYSE:ALTG) rents and sells construction, industrial, and other equipment. The shares are rated Buy on average and analysts have set an average share price target of $22.25.

As of Q3 2023 end, 16 out of the 910 hedge funds profiled by Insider Monkey were Alta Equipment Group Inc. (NYSE:ALTG)’s shareholders.

9. SSR Mining Inc. (NASDAQ:SSRM)

Average Analyst Share Price Target Percentage Upside: 76.50%

Average Share Price Target: $19.38

SSR Mining Inc. (NASDAQ:SSRM) is an American gold mining company headquartered in Denver, Colorado. The firm closed 2023 by divesting its stake in a subsidiary and completing the sale to a bank.

During this year’s September quarter, 14 out of the 910 hedge funds profiled by Insider Monkey had held a stake in SSR Mining Inc. (NASDAQ:SSRM).

8. Immatics N.V. (NASDAQ:IMTX)

Average Analyst Share Price Target Percentage Upside: 76.60%

Average Share Price Target: $19.32

Immatics N.V. (NASDAQ:IMTX) is a German biotechnology company developing cancer treatments. Its shares are rated Strong Buy on average and the average analyst share price target is $19.32.

As of Q3 2023 end, 33 out of the 910 hedge funds covered by Insider Monkey’s research were the firm’s shareholders. Julian Baker and Felix Baker’s Baker Bros. Advisors was the biggest Immatics N.V. (NASDAQ:IMTX) investor due to its $65.3 million stake.

7. Zynex, Inc. (NASDAQ:ZYXI)

Average Analyst Share Price Target Percentage Upside: 77.62%

Average Share Price Target: $19.13

Zynex, Inc. (NASDAQ:ZYXI) is a healthcare company that makes and sells nerve stimulation and other associated devices. Nearly 80% of its stock is held by either insiders or institutional investors, indicating that perhaps they have a strong conviction to remain majority shareholders.

For their third quarter of 2023 shareholdings, 13 out of the 910 hedge funds covered by Insider Monkey had bought Zynex, Inc. (NASDAQ:ZYXI)’s shares. The firm’s largest shareholder among these is Israel Englander’s Millennium Management as it owns 949,312 shares that are worth $7.5 million.

6. Altimmune, Inc. (NASDAQ:ALT)

Average Analyst Share Price Target Percentage Upside: 82.11%

Average Share Price Target: $22.29

Altimmune, Inc. (NASDAQ:ALT) is a biotechnology company with drugs in second phase trials for diseases such as hepatitis. The shares are rated Strong Buy on average and the average analyst share price target is $22.29.

After digging through 910 hedge funds for their Q3 2023 investments, Insider Monkey found that 17 had invested in Altimmune, Inc. (NASDAQ:ALT). The firm joins Evolus, Inc. (NASDAQ:EOLS), Relay Therapeutics, Inc. (NASDAQ:RLAY), and Valneva SE (NASDAQ:VALN) in our list of promising long term stocks.

Click here to continue reading and check out 5 Promising Long-Term Stocks According to Analysts.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

16 Most Promising Long-Term Stocks According to Analysts

Published on December 29, 2023 at 6:45 am by Ramish Cheema in News, Quantitative Investing

16 Most Promising Long-Term Stocks According to Analysts

16. Xperi Inc. (NYSE:XPER)

15. Tango Therapeutics, Inc. (NASDAQ:TNGX)

14. Tyra Biosciences, Inc. (NASDAQ:TYRA)

13. KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)

12. MAG Silver Corp. (NYSE:MAG)

11. Liquidia Corporation (NASDAQ:LQDA)

10. Alta Equipment Group Inc. (NYSE:ALTG)

9. SSR Mining Inc. (NASDAQ:SSRM)

8. Immatics N.V. (NASDAQ:IMTX)

7. Zynex, Inc. (NASDAQ:ZYXI)

6. Altimmune, Inc. (NASDAQ:ALT)

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: